Arcus Biosciences Inc (RCUS)
15.51
-0.44
(-2.76%)
USD |
NYSE |
May 07, 15:08
Arcus Biosciences Shares Outstanding: 90.86M for Feb. 14, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 14, 2024 | 90.86M |
January 29, 2024 | 90.09M |
December 31, 2023 | 75.50M |
November 01, 2023 | 74.86M |
September 30, 2023 | 74.86M |
August 02, 2023 | 74.50M |
June 30, 2023 | 74.50M |
May 03, 2023 | 73.11M |
April 18, 2023 | 73.08M |
March 31, 2023 | 73.10M |
March 01, 2023 | 73.02M |
February 17, 2023 | 73.01M |
December 31, 2022 | 72.90M |
October 28, 2022 | 72.41M |
September 30, 2022 | 72.35M |
July 29, 2022 | 72.16M |
June 30, 2022 | 72.09M |
April 29, 2022 | 71.72M |
April 18, 2022 | 71.71M |
March 31, 2022 | 71.62M |
March 01, 2022 | 71.24M |
February 12, 2022 | 71.06M |
December 31, 2021 | 70.78M |
October 29, 2021 | 70.25M |
September 30, 2021 | 70.24M |
Date | Value |
---|---|
July 30, 2021 | 71.39M |
June 30, 2021 | 71.37M |
April 30, 2021 | 71.00M |
April 09, 2021 | 70.99M |
March 31, 2021 | 70.97M |
March 01, 2021 | 70.89M |
February 12, 2021 | 70.88M |
December 31, 2020 | 65.11M |
October 31, 2020 | 64.92M |
September 30, 2020 | 64.92M |
July 31, 2020 | 64.91M |
June 30, 2020 | 58.94M |
June 28, 2020 | 58.71M |
June 02, 2020 | 57.06M |
May 22, 2020 | 46.06M |
April 30, 2020 | 46.05M |
April 09, 2020 | 45.98M |
March 31, 2020 | 45.98M |
March 01, 2020 | 45.97M |
February 28, 2020 | 45.97M |
December 31, 2019 | 45.92M |
October 30, 2019 | 45.86M |
September 30, 2019 | 45.84M |
July 30, 2019 | 45.85M |
June 30, 2019 | 45.85M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
45.84M
Minimum
Sep 30 2019
90.86M
Maximum
Feb 14 2024
65.77M
Average
70.99M
Median
Shares Outstanding Benchmarks
Gilead Sciences Inc | 1.247B |
Catalyst Pharmaceuticals Inc | 117.86M |
Integra Lifesciences Holdings Corp | 78.60M |
Vertex Pharmaceuticals Inc | 258.31M |
Adverum Biotechnologies Inc | 20.76M |